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Abstract
The cofactor nicotinamide adenine dinucleotide (NAD+) has emerged as a key regulator of metabolism, stress resistance
and longevity. Apart from its role as an important redox carrier, NAD+ also serves as the sole substrate for NAD-dependent
enzymes, including poly(ADP-ribose) polymerase (PARP), an important DNA nick sensor, and NAD-dependent histone
deacetylases, Sirtuins which play an important role in a wide variety of processes, including senescence, apoptosis,
differentiation, and aging. We examined the effect of aging on intracellular NAD+ metabolism in the whole heart, lung, liver
and kidney of female wistar rats. Our results are the first to show a significant decline in intracellular NAD+ levels and
NAD:NADH ratio in all organs by middle age (i.e.12 months) compared to young (i.e. 3 month old) rats. These changes in
[NAD(H)] occurred in parallel with an increase in lipid peroxidation and protein carbonyls (o- and m- tyrosine) formation and
decline in total antioxidant capacity in these organs. An age dependent increase in DNA damage (phosphorylated H2AX)
was also observed in these same organs. Decreased Sirt1 activity and increased acetylated p53 were observed in organ
tissues in parallel with the drop in NAD+ and moderate over-expression of Sirt1 protein. Reduced mitochondrial activity of
complex I–IV was also observed in aging animals, impacting both redox status and ATP production. The strong positive
correlation observed between DNA damage associated NAD+ depletion and Sirt1 activity suggests that adequate NAD+
concentrations may be an important longevity assurance factor.
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Introduction
Multiple degenerative processes are implicated in natural
senescence. As aging is associated with progressive decline in
organ function, elucidating the complex pathways controlling the
rate of aging is of significant clinical importance [1]. An important
mechanism contributing to aging is oxidative stress. The ‘‘free-
radical theory of aging’’, initially proposed by Harman (1956)
suggests that oxidative damage occurs with advanced aging due to
an imbalance between free radical and reactive species (ROS)
production, and cellular antioxidant defense mechanisms [2].
Elevated levels of intracellular ROS through hydrogen peroxide
treatment, or deficiency of ROS scavenging enzymes such as
superoxide dismutase (SOD1) knockdown, has been shown to
induce premature senescence and reduce cellular life span [3,4,5].
The mitochondria, represents the main producer of cellular
ROS in the human body, and approximately 1–2% of the oxygen
molecules consumed during normal respiration are converted into
highly reactive superoxide anion, which is rapidly dismutated to
H2O2 by the superoxide dismutases [6]. Other pathways and
events able to produce ROS include peroxisomal metabolism,
enzymatic synthesis of nitric oxide, phagocytic leukocytes, heat,
ultraviolet (UV) light, therapeutic drugs, and ionizing radiation
[7]. Intracellular ROS, due to their high reactivity, can interact
with a spectrum of biological molecules, leading to the oxidation of
several macromolecules, such as protein, lipids, and nucleic acids
[8]. As a result, vital functions, such as energy production,
maintenance of plasma membrane potential, and cellular ionic
homeostasis may be impaired in the early stage of oxidative stress
[8]. Excessive oxidative insult may also stimulate secondary events
leading to cell death via an apoptotic mechanism [9].
A major factor associated with age-related diseases is the increase of
oxidative DNA damage [7]. It is estimated that at least 5000 single-
s t r a n d e dD N Ab r e a k so c c u rd u r i n gas i n g l ec e l lc y c l ea sar e s u l to f
ROS production [10,11]. Approximately 1% of these DNA breaks are
converted into double-stranded DNA breaks, primarily during DNA
replication. Accumulation of unrepaired DNA damage induced by
ROS can lead to arrest or induction of transcription, induction of signal
transduction pathways, replication errors and genomic instability
[10,11]. These molecular changes are observed in both cancer and
aging, and this supports the notion that chronic oxidative damage to
DNA might trigger cancer and promote aging [10,11].
The removal of oxidative DNA damage through repair of
DNA single strand breaks by DNA base excision repair,
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[12,13,14]. PARP is an abundant protein modifying nuclear
enzyme involved in DNA repair. The enzymatic activity of
PARP is strongly activated in cells in response to treatment with
ROS such as H2O2 [15]. Activation of PARP leads to the
transfer of ADP-ribose moieties from NAD
+,t ot h et a r g e t
protein [16]. Since PARP uses NAD
+ as the only endogenous
substrate for poly-ADP-ribosylation, PARP activity is dependent
on the amount of NAD
+ available, and may act as a nuclear
energy sensor. Under physiological conditions, mild activation
of PARP can regulate several cellular processes, including DNA
repair, cell cycle progression, cell survival, chromatin remodel-
ing, and genomic stability [13,17]. However, overactivation of
PARP can repress genomic transcription and reduce cell
survival. NAD
+, in addition to being a substrate for PARP,
also serves as an important redox carrier to power oxidative
phosphorylation and ATP production [18]. Depletion of NAD
+
following PARP hyperactivation has been shown to deplete
intracellular ATP stores leading to the release of apoptosis-
inducing factors (AIF) and consequent cell death due to energy
restriction [19]. PARP activation has been implicated in the
pathogenesis of hypertension, atherosclerosis, lung injury,
haemorrhagic shock, and diabetic cardiovascular and kidney
complications [20,21,22,23,24]. In these diseases, the oxidant-
mediated endothelial cell injury is dependent on PARP
activation, and can be attenuated by pharmacological PARP
inhibitors [25,26]. Therefore, tight regulation of PARP activity
is crucial to prevent the development of several age-related
pathological disorders.
In addition to its role in PARP activity, another essential
factor that is greatly affected by changes in intracellular NAD
+
levels is the class III histone deacetylases known as sirtuins, or
silent information regulator of gene transcription [27]. Gene
silencing by this family of enzymes has been correlated directly
with longer lifespan in yeast and worms [28]. In yeast, sir2 plays
a critical role in transcriptional silencing and maintenance of
genomic stability [29,30]. Sirt1 is the human homolog of sir2
and appears to be involved in several physiological functions
including the control of gene expression, cell cycle regulation,
apoptosis, DNA repair, metabolism, and aging [31,32,33]. Sirt1
can deacetylate numerous proteins such as tumor suppressor
protein, p53, which modulates various genes that control
damaged DNA [34]. The deacetylase activity of SIRT proteins
is dependent on the intracellular NAD
+ content [27]. They
catalyse a unique reaction that releases nicotinamide, acetyl
ADP-ribose (AADPR), and the deacetylated substrate [27].
Impaired SIRT1 activity due to PARP mediated NAD
+
depletion allows increased activity of several apoptotic effectors
such as p53, therefore sensitising cells to apoptosis. Adequate
NAD
+ levels are therefore critical to maintaining Sirt1 activity
which can delay apoptosis and provide vulnerable cells with
additional time to repair even after repeated exposure to
oxidative stress [35].
Though a number of studies have demonstrated elevated levels
of oxidative stress associated damage in aged tissue, to our
knowledge, no study has yet reported on changes in NAD
+ levels
during the aging process. In this study, we have characterized and
quantified changes in NAD
+ metabolism in the liver, heart,
kidney and lung from female wistar rats aged from 3 to 24
months, spanning life stages from young adulthood to old age
[36]. We quantified the levels of oxidative stress (in the form of
protein carbonyls, lipid peroxidation, and oxidative DNA
damage), total antioxidant and NAD
+ levels and PARP, Sirt1
and mitochondrial activities in these tissues at different stages of
life. Our results suggest that oxidative stress induced NAD
+
depletion could play a significant role in the aging process, by
compromising, energy production, DNA repair and genomic
surveillance.
Materials and Methods
Reagents and Chemicals
Phosphate buffer solution (PBS) was from Invitrogen (Mel-
bourne, Australia). Nicotinamide, bicine, b-nicotinamide
adenine dinucleotide reduced form (b-NADH), 3-[-4,5-di-
methylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT),
alcohol dehydrogenase (ADH), sodium pyruvate, TRIS, c-
globulins, N-(1-naphthyl) ethylenediamine dihydrochloride,
EGTA, EDTA, tricarboxylic acid (TCA), Hepes, proteinase
K, Percoll, mannitol, 1,-dithio DL-threitol (DTT), KCN,
decylubiquinone, succinate, antimycin, rotenone, cytochrome
c, and sodium borohydride were obtained from Sigma-Aldrich
(Castle-Hill, Australia). Phenazine methosulfate (PMS) was
obtained from ICN Biochemicals (Ohio, USA). Bradford
reagent was obtained from BioRad (Hercules, CA, USA). DAPI
and polyclonal antibodies (pAb) for b-actin and all chemicals
used for Western blots (unless otherwise stated) were obtained
from Sigma-Aldrich (Castle-Hill, Australia). Polyclonal antibod-
ies for detection of (E)-4- Hydroxynonenal, Sirt1, phospho-
H2AX-ser139 were obtained from Alexis Biochemicals (San
Diego, CA, USA). Monoclonal antibody for the detection of
Poly(ADP-ribose) was purchased from Alexis Biochemicals (San
Diego, CA, USA). Polyclonal antibody for the detection of
acetylated p53 was obtained from Abcam (Cambridge, UK).
Monoclonal antibody to total p53 was obtained from Millipore
(Melbourne, Australia). Alexa 488- or Alexa 594-conjugated
anti-mouse IgG or anti-rabbit were purchased from Invitrogen.
All commercial antibodies were used at the concentrations
recommended by the manufacturer.
Table 1. List of primary antibodies used.
Antibody Type Antigen Dilution Source
(E)-4-Hydroxynonenal Polyclonal Free HNE (E)-4-hydroxynonenal 1:1000 Alexis Biochemicals
Phospho-H2AX-Serine139 Polyclonal Phosphorylated H2AX at Serine 139 1:1000 Alexis Biochemicals
Poly(ADP-ribose) (10H) Monoclonal Poly(ADP-ribose) 1:400 Alexis Biochemicals
Sirt1 Polyclonal Sirt1 1:2000 Alexis Biochemicals
Acetyl K386 Polyclonal Acetylated p53 at lysine 386 1:1000 Abcam
p53 Oncogene Monoclonal Total p53 oncogene 1:1000 Millipore
doi:10.1371/journal.pone.0019194.t001
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Female wistar rats were used and experiments were designed to
target the following age groups: 3 months old (equivalent to a
young human adult aged 20 years), 12 month old (equivalent to a
middle-aged human aged 40 years) and 24 month old (equivalent
to an aged human greater than 80 years) [37]. The animals were
individually housed in an environmentally controlled room under
a 12:12 hour light/dark cycle at 23uC and were given commercial
rat chow and water ad libitum. All experiments were performed
according to the Animal Ethics Committee of the University of
Sydney. Anaesthesia was induced with a mixture of O2,N O 2, and
5% halothane, and then maintained by an intraperitoneal
injection of sodium pentobarbitone (60 mg kg
21). Transcardial
perfusion was performed using 0.1 M DPBS, pH 7.4. Whole
heart, lung, liver and kidney, were removed, washed with DPBS
and used immediately for a variety of biochemical and
histochemical procedures.
Assay of o- and m- tyrosine for the Measurement of
Protein Carbonyl Formation
The assay for o- and m- tyrosine was performed as previously
described [38]. Briefly, calibration standards of phenylalanine
(313 pmol and 50 nmol) and o- and m- tyrosine (313 fmol to
50 pmol) were used for quantification. Labelled [
13C6]-phenylal-
anine was used as an internal standard and was added to all
samples and standards. The liver, heart, kidney and lung were
Figure 1. Increased formation of oxidatively modified proteins in the liver, heart, kidney, and lung with age. Increased levels of (A) o-
tyrosine and (B) m- tyrosine were reported in the brain after 12 months of age compared to 3 month old rats. All values are means 6 S.E from tissue
obtained from eight different rats for each age group. Significance
*p,0.01 compared to 3 month old rats.
doi:10.1371/journal.pone.0019194.g001
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precipitate (,18 h, 220uC) following the addition of 10 volumes
of acetone/HCl (100:1, v:v). The precipitate was centrifuged
(14,000 g, 30 min, ambient temperature) and the supernatant
discarded. Internal standard (10 ml, 1 mg/ml [
13C6]-phenylala-
nine) containing trace quantities of [
13C6]-tyrosine, was added to
all samples and standards, and dried under reduced pressure
(,1 Torr, 1–2 h). Afterwards, gas phase acid hydrolysis was
performed at 150uC for 1 h. Samples and standards were then
derivatised using a three-step derivatisation approach, using
heptafluorobutyric anhydride (HFBA), pentafluorobenzylbromide
(PFBBr) and N,O-bis(trimethylsilyl)-trifluoroacetamide (BSTFA),
vacuum dried for 10 min, and reconstituted in 50 ml ethyl acetate.
Each standard and sample (1 ml) was injected into the GC/MS
using pressure pulse splitless loading (6890N gas chromatograph
interfaced to 5973 mass selective detector; Agilent technologies,
Ryde, Australia), with methane as the ECNI reagent gas.
Chromatography was performed on a fused silica capillary column
(HP-5MS; 30 m60.25 mm i.d.60.25 mm, film thickness), with
helium carrier gas and using the following chromatographic
parameters: inlet temperature 250uC, transfer line temperature
280uC, programmed oven temperature gradient with initial
temperature of 150uC for 3 min, then a temperature ramp of
30uC/min to 290 and a final time of 3 min at 290uC. Final o- and
m- tyrosine levels were expressed relative to phenylalanine levels.
Western Blots for the Detection of 4-Hydroxynonenal,
Poly(ADP)-ribose, Sirt1, and Total/Acetylated p53 Protein
Expression
The whole liver, heart, kidney and lung were homogenised in
RIPA lysis buffer containing 50 mM Tris-HCl (pH 7.4);
IGEPAL 1%; 0.25% Na-deoxycholate; 1 mM EDTA,
150 mM NaCl; 1 mg/ml each of aprotinin, leupeptin and
pepstatin; 1 mM Na3VO4;a n d1 m MN a F .A f t e r1 h ,t h e
homogenate was obtained by centrifuging at 14,000 g, for
30 min at 4uC. Protein concentration was determined using the
Bradford protein assay. Equal amounts of protein extract
(30 mg) were dissolved in Laemmli sample buffer (Hercules,
CA, USA), boiled for 5 min, electrophoresed on 8–12% (v/v)
polyacrylamide SDS-PAGE gels (BioRad, Hercules, CA, USA),
and electrotransferred onto PVDF membranes (BioRad, Her-
cules, CA, USA). Membranes were blocked with 5% non-fat
milk dissolved in TBS for 1 h and incubated with primary
antibody overnight at 4uC. The primary antibodies used are
described in Table 1. After incubation with primary antibodies,
membranes were washed in TBS-Tween-20 and incubated with
HRP conjugated secondary antibodies (Sigma, Castle Hill,
Australia) for 1 h at room temperature. After further washing in
TBS-Tween-20, the membranes were incubated with an ECL
plus reagent (RPN2132, Amersham) and protein bands were
visualised on X-ray films. The bands were quantified by ImageJ
software, and normalised to b-actin, which served as an internal
control.
Total Antioxidant Capacity Assay
The total antioxidant capacity in aging liver, heart, kidney and
lung was evaluated by Trolox equivalent antioxidant capacity
assay using a standard antioxidant assay kit (Cayman, Michigan,
USA). Briefly, the tissue was homogenised on ice in a buffer
containing 5 mM potassium phosphate; 0.9% NaCl; and 0.1%
glucose, pH 7.4. The samples were centrifuged at 10,000 g for
15 min at 4uC, and the supernatant was collected for the assay.
Figure 3. Total antioxidant capacity significantly declined in the rat liver, heart, kidney, and lung with age. All values are means 6 S.E
from tissue obtained from eight different rats for each age group. Significance
*p,0.01 compared to 3 month old rats.
doi:10.1371/journal.pone.0019194.g003
Figure 2. Increased oxidative damage to lipids in selected brain regions with age. (A) Liver, (B) heart, (C) kidney, and (D) lung were
analysed by Western blotting using anti-4HNE antibody. The blots shown are representative tracings of an experiment done eight times. Graphs are
mean 6 S.E from tissue obtained from eight different rats for each age group. Each bar of the quantification graph represents the corresponding
band for each age group. Significance
*p,0.01 compared to 3 month old rats. (E) Immunodetection of 4-HNE in the liver, heart, kidney, and lung from
3 month, 12 month and 24 month old rats. 4-HNE (green) and DAPI (blue). Higher immunoreactivity for 4-HNE was observed in 12 and 24 month old
rats compared to 3-month old rats.
doi:10.1371/journal.pone.0019194.g002
Age Related Changes in NAD+ Metabolism
PLoS ONE | www.plosone.org 5 April 2011 | Volume 6 | Issue 4 | e19194Briefly, 10 ml of sample was added to 10 ml of Metmyoglobin and
150 ml of Chromogen. The reaction was initiated by adding 40 ml
of hydrogen peroxide working solution. The samples were
incubated on a shaker for 5 min at room temperature and the
absorbance was read at 405 nm using the Model 680XR
microplate reader (BioRad, Hercules). The absorbance values
obtained for the samples were compared with a standard curve
obtained using Trolox (6-hydroxy-2,5,7,8-tetramethyl-chroman-2-
Figure 4. Increased DNA damage was reported in the rat liver, heart, kidney, and lung with age. (A) DNA damage was determined by
measuring the flourescence of phosphorylated H2AX at Serine139 using the Fluostar Optima Fluorometer (NY, USA). All values are means 6 S.E from
tissue obtained from eight different rats for each age group. Significance
*p,0.01 compared to 3 month old rats. (B) Immunodetection of phosphor-
H2AX-Serine139 in the liver, heart, kidney, and lung from 3 month, 12 month and 24 month old rats. Phosphor-H2AX-Serine139 (green) and DAPI
(blue). Higher immunoreactivity for phosphor-H2AX-Serine139 was observed in 12 and 24 month old rats compared to 3-month old rats.
doi:10.1371/journal.pone.0019194.g004
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commonly employed as an antioxidant. The results were expressed
as mmol Trolox/L/mg protein.
DNA Damage Assay
Since H2AX phosphorylation at serine 139 correlates very
closely with each double-stranded DNA break, phosphor-H2AX
is a sensitive marker for DNA damage [39]. We measured
phosophorylation of H2AX at serine 139 using a DNA damage
assay kit (Active Motif, Carlsbad, California, USA). Briefly, the
liver, heart, kidney and lung was suspended on ice in a buffer
containing 1 mM PMSF and pelleted at 10,000 g for 4 min at
4uC. Afterwards 200 ml of warm SDS lysis buffer containing
1 mg/ml each of aprotinin, leupeptin and pepstatin and 1 mM
PMSF were then added and incubated for 10 min on ice. All
samples were sonicated to generate 100 - to 1000-bp DNA
fragments. 5 mg/ml of anti-phospho-H2AX-ser139 was added to
the lysate with cold DPBS and allowed to incubate overnight at
4uC. The primary antibody was removed by washing the lysate 3
times with 200 ml DPBS. Alexis 488 goat anti-rabbit IgG
secondary antibody (1:1000) was added to the lysate and
incubated for 1 hour at room temperature. The secondary
antibody was removed by washing the lysate twice with 200 ml
DPBS. The fluorescence was read using Fluostar Optima
Fluorometer (NY, USA). Filter excitation and emission was set
at 485 nm and 520 wavelengths respectively.
Isolation and Extraction of Nuclei for PARP and Sirt1
deacetylase Activity Assays
Aliquots of homogenate from the liver, heart, kidney and lung
(without protease inhibitors) were spun through 4 ml of 30%
sucrose solution containing 10 mM Tris HCl (pH 7.4); 10 mM
NaCl; and 3 mM MgCl2 at 1,300 g for 10 min at 4uC. The
remaining pellet was washed with cold 10 mM Tris-HCl (pH 7.4)
containing 10 mM NaCl. The nuclei was later suspended in 50–
100 ml extraction buffer containing 50 mM Hepes KOH (pH 7.4);
420 mM NaCl; 0.5 mM EDTA; 0.1 mM EGTA; and glycerol
10%, sonicated for 30 s, and allowed to stand on ice for 30 min.
After centrifugation at 10,000 g for 10 min, an aliquot of the
supernatant was used to determine protein concentration using the
Bradford protein assay.
PARP Activity Assay
PARP activity was measured in nuclear extracts from the liver,
heart, kidney and lung of young, middle-aged, and aged rats, using
a new operational protocol relying on the chemical quantification
of NAD
+ modified from Putt et al. [40]. The final reaction mixture
contained 10 mM MgCl2, Triton X-100 (1%), and 20 mM NAD
+
in 50 mM Tris buffer, pH 8.1. The plate was then incubated for
1 hour and the amount of NAD
+ consumed was measured by the
NAD(H) microcycling assay using the Model 680XR microplate
reader (BioRad, Hercules). The results were expressed as NAD
+
consumed/h/mg protein.
Sirt1 deacetylase Activity
Sirt1 deacetylase activity was evaluated in nuclear extracts from
the liver, heart, kidney and lung of young, middle-aged, and aged
rats, using the Cyclex SIRT1/Sir2 Deacetylase Flourometric
Assay Kit (CycLex, Nagano, Japan). The final reaction mixture
(100 ml) contained 50 mM Tris-HCl (pH 8.8), 4 mM MgCl2,
0.5 mM DTT, 0.25 mA/ml Lysyl endopeptidase, 1 mM Trichos-
tatin A, 200 mM NAD
+, and 5 ml of nuclear sample. The samples
were mixed well and incubated for 10 min at room temperature
and the fluorescence intensity (ex. 340 nm, em. 460 nm) was
measured every 30 s for a total of 60 min immediately after the
addition of fluorosubstrate peptide (20 mM final concentration)
using Fluostar Optima Fluorometer (NY, USA) and normalised by
the protein content. The results are reported as relative
fluorescence/mg of protein (AU).
Measurement of Intracellular NAD
+/NADH Levels
Total intracellular NAD (NADH+NAD
+) concentration was
measured spectrophotometrically using the thiazolyl blue micro-
cycling assay established by Bernofsky and Swan (1973) adapted
for 96 well plate format by Grant and Kapoor (1998) [41,42].
Briefly, each assay contained 100 mM bicine, pH 7.8; 0.42 mM
MTT, and 1.66 mM PMS. For NAD
+ measurement, 20 mlo f
ADH in 0.15% ethanol was added to the reaction mixture. The
amount of NAD and NADH were measured as the change in
absorbance at 590 nm at 37uC for 10 minutes with a Model
680XR microplate reader (BioRad, Hercules). The ratio of
NAD
+/NADH was calculated based on results of NAD
+ and
NADH concentrations.
Isolation of Mitochondria
All procedures were carried out at 0–4uC. Briefly, the liver,
heart, kidney and lung were excised, washed with DPBS, and
treated with proteinase K (1 mg/ml) for 30 s, washed with buffer
A (250 mM mannitol; 0.5 mM EGTA; 5 mM Hepes; and fatty
acid free bovine serum albumin 0.1%, pH 7.4 at 4uC). The
samples homogenised with buffer A using a Teflon pestle. The
homogenate was centrifuged twice at 600 g for 5 min at 4uC. The
supernatants were mixed and centrifuged at 10,300 g for 10 min
at 4uC. The mitochondrial pellets were suspended in 0.5 ml buffer
A and transferred to ultracentrifuge tubes containing 1.4 ml buffer
B (225 mM mannitol; 1 mM EGTA; 25 mM Hepes; and fatty
acid free bovine serum albumin (BSA) 0.1%, pH 7.4 at 4uC) and
0.6 ml Percoll. The mixture was centrifuged at 105,000 g for
30 min at 4uC. The pure mitochondrial fraction was purified by
washing twice with buffer A at 10,300 g for 10 min at 4uCt o
remove the Percoll and frozen to 280uC. An aliquot was used to
determine the mitochondrial protein content using the Bradford
protein assay.
Determination of Mitochondrial Complexes I, II, III, and IV
activities
To determine the complex I activity, submitochondrial
fractions (0.6 mg/ml) were incubated for 3 min in buffer solution
Figure 5. Increased Poly(ADP-ribose) activity in the brain with age. (A) PARP activity was determined in aging tissue using a
spectrophotometric assay. All values are means 6 S.E from tissue obtained from eight different rats for each age group. Significance
*p,0.01
compared to 3 month old rats. (B) Western blotting for poly(ADP-ribose) in (i) liver, (ii) heart, (iii) kidney, and (iv) lung with aging using anti-Poly(ADP-
ribose) (10H) antibody. The blots shown are representative tracings of an experiment done eight times. Graphs are mean 6 S.E from tissue obtained
from eight different rats for each age group. Each bar of the quantification graph represents the corresponding band for each age group. Significance
*p,0.01 compared to 3 month old rats. (C) Immunodetection for poly(ADP-ribose) in the liver, heart, kidney and lung from 3 month, 12 month and 24
month old rats. Poly(ADP-ribose) (green) and DAPI (blue). Higher immunoreactivity for poly(ADP-ribose) was observed in 12 and 24 month old rats
compared to 3-month old rats.
doi:10.1371/journal.pone.0019194.g005
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1m M K C N ; 5 0mM decylubiquinone; 0.8 mM antimycin,
pH 7.4. The reaction was started following the addition of
NADH (100 mM). The activity of NADH CoQ oxidoreductase
was measured as the rate of oxidation of NADH at 340 nm using
the Model 680XR microplate reader (BioRad, Hercules). The
activity of complex I was expressed as nmol oxidised NADH/
min/mg protein. The activity of complex II was measured in
buffer solution containing submitochondrial fractions (0.03 mg/
ml); 100 mM potassium-phosphate; 20 mM succinate; 0.8 mM
antimycin; 50 mM rotenone; 2 mM KCN; 50 mM DCIP, pH 7.4.
The reaction was initiated by the addition of 50 mM decylubi-
quinone. The activity of succinate:DCIP oxireductase was
measured as the rate of reduction of 2, 6-DCIP at 600 nm with
520 nm as reference wavelength. The activity of complex II was
expressed in nmol reduced DCIP/min/mg protein. The activity
of complex III was measured in buffer solution containing
submitochondrial fractions (0.03 mg/ml); 35 mM potassium-
phosphate; 5 mM MgCl2; 2.5 mg/ml BSA; 50 mM rotenone;
1.8 mM KCN; 2 mM decylubiquinone, pH 7.5. The reaction
was initiated by the addition of 125 mM cytochrome c.T h e
activity of ubiquinol:cytochrome c reductase was measured as the
rate of reduction of cytochrome c at 550 nm with 580 nm as the
reference wavelength. The activity of complex III was expressed
in nmol reduced cytochrome c/min/mg protein. The activity of
complex IV was measured in a buffer solution containing
submitochondrial fractions (0.1 mg/ml); 50 mM potassium-
phosphate, pH 6.8. The reaction was started by the addition of
75 mM cytochrome c previously reduced with sodium borohy-
dride and measuring the absorbance at 550 nm. The activity of
cytochrome c oxidase was expressed as nmol oxidised cytochrome
c/min/mg protein.
Immunoflourescence Staining for 4-Hydroxynonenal,
Phospho-H2AX-Serine139, Poly(ADP)-ribose, and Sirt1
Liver, heart, kidney and lung whole mounts were immersion-
fixed with ice cold 70% ethanol for 20 mins followed by 4%
paraformaldehyde (PFA), pH 7.4 for 10 min at 4uC. Immuno-
staining was established on brain whole mount. Fixed tissue were
permeabilised with 1% Triton-X 100 in DPBS for 30 min at
room temperature and non-specific binding was blocked with 1%
BSA in DPBS for 2 h before application of primary antibodies.
All specific primary mAb or pAb antibodies were diluted in 1%
BSA in PBS and incubated overnight at 4uC. Tissue whole
mounts were washed three times with DPBS and incubated for
1 h at 37uC with the appropriate labeled secondary antibodies
(goat anti-mouse IgG or goat anti-rabbit IgG coupled to Alexa
488 or Alexa 594). Nuclear staining was performed using DAPI at
1 mg/ml for 5 min at room temperature. The slides were washed
3 times in DPBS at room temperature and coverslips were
mounted on glass slides with Flouromount-G and were examined
with an Olympus BX60 fluorescence microscope fitted with a
SensiCam digital camera. Titration series and conjugate
experimental controls were performed on both primary and
secondary antibodies to optimise for low background noise,
maximal stain sensitivity, avoidance of non-specific staining and
cross-reactivity.
Bradford Protein Assay for the Quantification of Total
Protein
DNA damage, total antioxidant capacity, PARP and Sirt1
activities, NAD
+ concentration, and mitochondrial function were
adjusted for variations in protein number using the Bradford
protein assay described by Bradford [43].
Data Analysis
Results obtained are presented as the means 6 the standard
error of measurement (SEM) of at least eight animals per age
group analysed in duplicate. One way analysis of variance
(ANOVA) and post hoc Tukey’s multiple comparison tests were
used to determine statistical significance between treatment
groups. Differences between treatment groups were considered
significant if p was less than 0.05 (p,0.05).
Results
Age-related Increase in Protein Carbonyl Formation
Hydroxyl radical attack on the amino acid phenylalanine
generates o-, m- and p- tyrosine were detected using gas
chromatography/mass spectrometry (GC/MS) [44,45]. Figure 1
shows the age-related changes in o- (Fig. 1A) and m- tyrosine
(Fig. 1B) levels in the liver, heart, kidney and lung. Our results
show a significant increase in both o- and m- tyrosine formation
with age, with the highest rate of increase occurring after 12
months of age in all organs (p,0.01).
4-HNE as a Biomarker for Lipid Peroxidation in Aging
Peroxidative damage to cellular lipid constituents was deter-
mined by using 4-HNE as a marker of lipid peroxidation.
Increased 4-HNE protein expression using western blotting was
observed in the liver (p,0.01) (Fig. 2A), heart (p,0.01) (Fig. 2B),
kidney (p,0.01) (Fig. 2C) and lung (p,0.01) (Fig. 2D), consistent
with an increase in protein carbonyl formation (Fig. 1).Using
immunohistofluorochemistry, we stained frozen sections for 4-
HNE (Fig. 2E). Two age related changes are clearly visible: (1)
There is an increase in 4-HNE expression consistent with the
previous western blot studies (Fig. 2A–D). (2) Aged tissue appears
to demonstrate significantly lower cell volume, indicative of
extensive cell loss occurring during the aging process.
Total Antioxidant Capacity Declines with Aging
To investigate changes in endogenous antioxidant function age,
we measured total antioxidant capacity in-situ using the Trolox
assay. We observed a significant reduction in total antioxidant
activity by 12 months of age in all organs with the most rapid
decline occurring between 12 and 24 months (p,0.01) (Fig. 3).
DNA Damage Increases with Aging
The aging process is also considered to cause changes in the
DNA repair process leading to increased vulnerability to DNA
damage [7]. We assessed DNA damage by measuring the
phosphorylation of H2AX at Serine139 residue using a flouro-
metric assay. Increased DNA damage was observed in all aged
organs assessed in this study by 12 months of age with accelerated
Figure 6. Increased PARP activation alters pyridine nucleotide metabolism with aging. (A) NAD
+ content and (B) NADH content were
determined in the rat liver, heart, kidney and lung with aging using a spectrophotometric assay. All values are means 6 S.E from tissue obtained from
eight different rats for each age group. Significance
*p,0.01 compared to 3 month old rats. (C) NAD
+:NADH ratio was determined as the total NAD
+
content divided by total NADH levels. All values are means 6 S.E from tissue obtained from eight different rats for each age group. Significance
*p,0.01 compared to 3 month old rats.
doi:10.1371/journal.pone.0019194.g006
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Immunohistofluorochemistry (Fig. 4C) confirmed the increase in
phospho-H2AX-Serine139.
PARP Activation & Poly(ADP-ribose) polymers
To demonstrate a direct link between DNA damage and poly-
ADP-ribosylation, we measured PARP activity in nuclei from the
liver, heart, kidney and lung of aging rats. Our results show a
significant (p,0.01) up-regulation of PARP activity in all organs
by 12 months of age (Fig. 5A). This is consistent with increased
formation of poly(ADP-ribose) nuclear protein in the liver (Fig. 5B),
heart (Fig. 5C), kidney (Fig. 5D),and lung (Fig. 5E), using western
blot and immunohistofluorochemistry (Fig. 5F).
Intracellular NAD
+(H) Levels
As NAD
+ is the sole substrate for PARP we assessed the impact
of PARP activation on intracellular NAD
+ content in the same
aging rat tissue. We found that increased PARP activity was
associated with a significant (p,0.01) reduction in the NAD
+
content by 24 months of age in each of the organs investigated
(Fig. 6A). This is in line with a significant increase in NADH
(Fig. 6B) (p,0.01) and a significant decline in the NAD
+:NADH
ratio (Fig. 6C) (p,0.01). Most of the decline in intracellular NAD
+
content was observed after 12 months of age, and appears to be
more noteworthy in the heart.
Sirt1 deacetylase Activity (but not protein levels) Declines
with Aging
Sirt1 is localised in the nucleus [27]. Therefore, both Sirt1
protein level and activity were measured in the liver, heart, kidney
and lung of aging rats. Aging induced a significant decline in Sirt1
activity in the liver (p,0.01), heart (p,0.01), kidney (p,0.01), and
lung (p,0.01) (Fig. 7A) consistent with decreased substrate
(NAD+) availability (Fig. 6). In contrast, we observed that aging
significantly (p,0.01) increased the amount of Sirt1 protein in the
nucleus in all organs examined in this study, using both western
blotting (Fig. 7B–E) and immunohistofluorochemistry (Fig. 7F).
Increased p53 Acetylation in Aging Brain
To confirm the effect of decreased NAD
+ levels and Sirt1
function on the acetylation status of p53, we measured both
acetylated and total p53 protein levels using western blotting. As
shown in Figure 8, we found a significant age-dependent increase
in acetylated p53 expression in the liver (p,0.01), heart (p,0.01),
kidney (p,0.01), and lung (p,0.01). However, no change was
observed in total p53 content between young and aged rats in all
organs investigated.
Impaired Mitochondrial Respiratory Chain Activity with
Aging
Although mitochondrial production of ROS has been shown to
increase with advancing age [46], changes in the mitochondrial
redox status with age in the heart, lung, liver and kidney has not,
to our knowledge, been evaluated. We measured the activities of
the mitochondrial respiratory complexes as shown in Figure 9A–
D. The activity of all complexes decreased after 12 months of age,
and reached statistical significance at 24 months in the liver
(p,0.01), heart (p,0.01), kidney (p,0.01) and lung (p,0.01).
Fig. 8E shows the ATP levels determined in all organs during the
aging process. ATP levels significantly (p,0.01) declined in the
heart, lung, liver and kidney after 12 months of age. This is in line
with increased PARP activation and decline in cellular NAD
+
content during the aging process.
Discussion
There is growing consensus around the hypothesis that
oxidatively damage proteins, lipids, and nucleic acids play a key
role in the aging process. Oxidative stress occurs in several
degenerative diseases including neurodegenerative disease (e.g.
Alzheimer’s, Parkinson’s), rheumatoid arthritis, atherosclerosis,
diabetes, and cardiovascular disease [47]. This study is the first to
investigate the impact of age associated changes in oxidative stress
levels on both intracellular NAD
+ levels and activity of the
‘longevity’ enzyme Sirt1. This study is also the first to report
changes in o- and m- tryosine (specific markers of protein
oxidation) in aging heart, lung, liver and kidney.
In this report we provide consistent evidence of accumulating
oxidative damage to tissue proteins, lipids and nuclear DNA with
age. Reactive oxygen species (ROS) are byproducts of normal
cellular physiology [48]. A delicate balance between ROS
generation and detoxification is maintained by several cellular
antioxidant defense systems [49,50]. These comprise antioxidant
enzymes such as SOD1, catalase, glutathione peroxidase; and
endogenous non-enzymatically acting compounds, such as
vitamins A, C and E [9]. Nevertheless, various endogenous
and exogenous triggers may stimulate the overproduction and
accumulation of ROS leading to oxidative damage [9]. While
oxidative stress increases with aging, it is yet unclear at which
age free-radicals may act to initiate the senescence process.
Young and aged rat models are relatively homogenous in their
gene expressions in the various organs. This may be in contrast
to young adult and aged human populations which may
demonstrate much greater heterogeneity. Unlike aged rodents,
humans may diverge in their rates of aging, as they translate
from middle age to old age. In this study at middle age (i.e.12
months), female wistar rats already exhibit higher levels of
oxidative stress induced damage to proteins, lipids, and DNA,
with a lower total antioxidant efficiency than young adult
animals of 3 months of age. Our results suggest an age-
dependent increase in oxidative stress in these organs that
appears to accelerate after middle age (i.e.12 months). These
data support the existence of a progressive disequilibrium
between the formation of ROS and the antioxidant protective
mechanisms during the process of normal aging [9] in rats that
may be applicable to the human population.
Apart from increased levels of protein oxidation and lipid
peroxidation, DNA is also susceptible to oxidative damage by
ROS [7]. We assessed DNA damage by measuring the
Figure 7. Reduced NAD
+ levels contributes to reduced Sirt1 activity in the liver, heart, kidney and lung with aging. (A) Reduced Sirt1
activity was observed in the rat liver, heart, kidney and lung after 12 months of age using a flourometry. All values are means 6 S.E from tissue
obtained from eight different rats for each age group. Significance
*p,0.01 compared to 3 month old rats. (B) Western blotting for Sirt1 in (i) liver, (ii)
heart, (iii) kidney, and (iv) lung with aging using anti-Sirt1 antibody. The blots shown are representative tracings of an experiment done eight times.
Graphs are mean 6 S.E brains from tissue obtained from eight different rats for each age group. Each bar of the quantification graph represents the
corresponding band for each age group. Significance
*p,0.01 compared to 3 month old rats. (C) Immunodetection for Sirt1 in the liver, heart, kidney
and lung from 3 month, 12 month and 24 month old rats. Sirt1 (red) and DAPI (blue). Higher immunoreactivity for Sirt1 was observed in 12 and 24
month old rats compared to 3-month old rats.
doi:10.1371/journal.pone.0019194.g007
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phosphorylation is considered a specific reporter of double-
stranded DNA damage [39]. The level of DNA damage increased
with age in all organs consistent with an increase in protein
carbonyls and lipid peroxidation. Experimental data from other
laboratories have shown a similar increase in DNA damage, (e.g.
8-oxoguanine) in the heart, lung, liver and kidney of aging rats
[51].
The DNA damage associated with oxidative stress is known to
activate the NAD
+-dependent DNA repair enzyme, PARP,
which assists in combination with the enzymes of the base-
excision-and-repair complex of the cell in energy-consuming
repair processes [12,52,53]. The vital role of PARP activation in
several diseases has been obtained from experimental studies
using PARP inhibitors, PARP knock-down mice, and clinical
trials. Recent studies have shown the protective effects of PARP
inhibitors on ischaemic heart and liver, diabetic kidney disease,
and endotoxin-induced acute lung injury, arguably due to the
preservation of NAD
+ levels [20,21,22,23,24]. PARP activation
can also promote apoptosis by stabilising p53, and mediating the
translocation of apoptosis-inducing factor from mitochondria to
the nucleus [19,54]. Several lines of evidence reported here
show that PARP activation increases in the aging heart, lung,
liver, and kidney (Fig. 5), and depletes cellular NAD
+ levels
(Fig. 6). Theoretically this should lead to a reduction in Sirt1
deacetylase activity and accumulation of acetylated p53.
Consistent with this prediction we observed that increased
PARP activation (Fig. 5) was associated with NAD
+ depletion
(Fig. 6) which was accompanied by a decrease in Sirt1
deacetylase activity (Fig. 7).
It is well established that genotoxic stress can kill cells by
depleting the intracellular NAD
+ pools due to extensive use of
NAD
+ as a substrate for PARP [12,13,16,19]. Results from the
present study, consistent with others, suggests that both PARP and
Sirt1 compete for the same limiting intracellular NAD
+ pool [55].
One study showed that PARP activation depleted intracellular
NAD
+ levels and reduced Sirt1 deacetylase activity in DNA
damaged in cardiac myocytes [55]. Replenishing intracellular
NAD
+ levels by increasing NAD
+ levels was able to restore cellular
viability but only in the presence of functional Sirt1 [55]. As NAD
+
serves as a cofactor for key glycolytic and mitochondrial enzymes,
vulnerable cells subsequently lose their ability to carry out energy
dependent functions including the maintenance of cell wall
integrity and DNA/RNA synthesis and consequently die [56].
We demonstrated, for the first time, that aging in the rat is
associated with decreased tissue levels of NAD
+. This may lower
the rate of cell survival in response to several endogenous and
exogenous stressors. As NAD
+ is the only substrate for both PARP
and Sirt1 activities, maintaining optimal NAD
+ content is crucial
to counteract the age-related degeneration observed during the
aging process [56,57].
As a substrate for the sirtuin family of NAD
+ dependent
deacetylases, known as silent information regulators of gene
function [27]. This discovery suggests that gene silencing by
this system might be related to metabolic rate and hence to
NAD
+ concentrations, whose levels therefore may be directly
proportional to a longer lifespan [28]. While several studies
have demonstrated the protective roles of sirtuin activators
during aging [30,34,35,58,59,60,61,62,63], little is known
regarding role of Sirt1 in the aging heart, lung, liver, and
kidney.
The present results show that aging increases the amount of
available Sirt1 protein and activities of Sirt1 in nuclear extracts
in the heart, lung, liver, and kidney. The activity per molecule of
Sirt1 appears to become lower in these organs as the animal
ages, suggesting the presence of more inactive or less active
molecules in aged animals. These observations are in line with a
previous study which reported a decrease in Sirt1 activity but
not Sirt1 protein expression in skeletal muscle of aged rats
[64].Two possibilities, which are not mutually exclusive, may
explain this observation: 1) Oxidative damage may potentially
inhibit Sirt1 activity in a similar way to several other proteins
[65] and/or 2) It is also likely that the age-associated drop in
NAD
+ content due to increased demand by PARP in the DNA
repair process limits the Sirt1 substrate NAD
+ thereby limiting
Sirt1 activity. A compensatory mechanism which increases the
production of the Sirt1 protein [64] would increase its relative
success when competing for the limited NAD
+ pool.. Sirt1
deficiency has been shown to accentuate apoptosis of renal
medullary cells [66] and cardiac mycocytes [55]. Over-
expression of Sirt1 has been shown to promote the resistance
of these cells to oxidative insult, both in vitro and in vivo [67]. The
protective function of Sirt1 has been reported in other organs
such as the heart, neurons, lung, liver [67,68,69,70]. Given the
pivotal role of Sirt1 as an anti-stress and anti-aging protein,
targeting Sirt1 by either Sirt1 activators or increasing its
substrate (i.e. NAD
+) availability may prove therapeutically
beneficial for the prevention of age-related cardiovascular,
respiratory, hepatic, and renal dysfunction.
Because Sirt1 activity is affected by the NAD
+:NADH ratio
[71], we determined the NAD
+ and NADH content in aging
heart, lung, liver, and kidney. Our results show a significant
decline in the NAD
+:NADH ratio with aging, consistent with a
decline in NAD
+ levels and an increase in NADH levels. This
indicates that age related metabolic changes may influence NAD
+
and NADH upstream of Sirt1 similar to what was observed in
yeast Sir2a and in the skeletal muscle [71].
To examine the downstream effect of Sirt1 deacetylase
activity in cellular processes, we measured the expression of
both total and acetylated p53 in aging rat tissue. The main
tumour suppressor protein, p53 regulates the expression of
several gene products that either lead to cell cycle arrest in G1
phase and prevent DNA replication immediately before the
repair of damage, or cause cell death via an apoptotic
mechanism [72]. We observed a significant increase in
acetylated p53 protein while no change was observed in total
p53 protein in all organs was apparent. Higher acetylation levels
of p53 have been reported in cardiac myocytes following
treatment with the oxidant H2O2, probably resulting from
decreased NAD
+ and impaired Sirt1 deacetylase activity [55]. A
recent report showed that microRNA 34a (miR-34a), a tumour
suppressor gene inhibiting Sirt1 expression also increases
acetylated p53 levels, thus stimulating transcriptional targets of
p53 responsible for promoting cell-cycle arrest, and apoptosis
Figure 8. Reduced Sirt1 activity induces p53 acetylation in the liver, heart, kidney and lung with aging. Acetylated p53 and total p53
levels were determined by Western blotting in (A) liver, (B) heart, (C) kidney, and (D) lung with aging using anti-acetylated p53 and anti-total p53
antibodies. The blots shown are representative tracings of an experiment done eight times. Graphs are mean 6 S.E brains from tissue obtained from
eight different rats for each age group. Each bar of the quantification graph represents the corresponding band for each age group. Significance
*p,0.01 compared to 3 month old rats.
doi:10.1371/journal.pone.0019194.g008
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poly(ADP-ribosylated), an effect which enhances their pro-
apoptotic activity, Sirt1-dependent deacetylation inhibits their
apoptotic activity [55]. These results suggest that changes in
intracellular NAD
+ levels may regulate the post-translational
acetylation of p53, thus providing further evidence of the
association between NAD
+ levels, oxidative DNA damage-
mediated PARP activation, and reduced Sirt1 deacetylase
activity [55].
One factor which may sensitise cells to increased DNA
damage is impaired mitochondrial function [74]. The mito-
chondrial electron transport system can trigger the formation
of superoxide leading to increased production of H2O2 by
superoxide dismutase [49,50]. Reduced electron flow through
the mitochondrial respiratory chain, particularly through the
inhibition of complex I or complex III, favours the enhanced
production of superoxide and H2O2 [75]. Together, with the
age-dependent increase in oxidative stress and decline in
NAD
+ and ATP content, we found a tendency to the reduction
in the activity of the respiratory complexes with age in all
organs. Sipos et al. (2003) showed that mitochondrial
formation of H2O2 due to complex I inhibition is more
clinically relevant than ROS production due to inhibition of
complex III and IV in situ [76]. Using the same experimental
paradigm, Rodriguez et al. (2008) reported similar mitochon-
drial oxidative failure in the diaphragm of senescent prone
mice [49].
It has also been demonstrated that an increased NADH:NAD
+
ratio, favours ROS generation by the catalytic activity of
a-Ketoglutarate dehydrogenase (a KGDH) [77]. The dependence
on ROS production by a KGDH on the intracellular NADH
content may play a crucial role in promoting the accumulation of
free radicals in aging. When the reoxidation of NADH is impaired
due to reduced complex I activity, the NADH:NAD
+ ratio
increases, thus reducing the activity of several NAD
+ dependent
dehydrogenases [77]. Moreover, NADH is also able to promote
the formation of H2O2 in the presence of iron [78]. Given the
observations in the present study, increased ROS production in
aging may be a consequence of impaired mitochondrial
respiratory function, and may, at least in part, be attributed to
increased NADH:NAD
+ ratio inducing free radical production via
aKGDH and Fenton chemistry.
Overall, our results show that oxidative stress increased with
age, (appearing to accelerate more rapidly after mid life), in
association with reduced antioxidant defence mechanisms, and
mitochondrial dysfunction; data consistent with the predictions of
the free-radical theory of aging. The current study, however,
provides new insight into the potential mechanisms of aging
involved in response to oxidative damage, particularly focusing
on NAD
+ metabolism and the roles of PARP and Sirt1 in the
heart, lung, liver, and kidney (Fig. 10). Adequate NAD
+
concentrations may therefore be an important longevity assur-
ance factor.
Therefore, we hypothesize that strategies targeted toward
maintaining adequate NAD
+ content during the aging process
may prove a novel and potentially effective mechanism for
retarding oxidative stress mediated cell degeneration, and age
associated disorders.
Figure 9. Oxidative stress-mediated reduction in mitochondrial respiratory chain activity in the liver, heart, kidney and lung with
age. Reduced (A) complex I, (B) complex II, (C) complex III, and (D) complex IV, activities at 24 months of age. All values are means 6 S.E from tissue
obtained from eight different rats for each age group. Significance
*p,0.01 compared to 3 month old rats.
doi:10.1371/journal.pone.0019194.g009
Figure 10. Schematic representation for the association between oxidative stress, PARP-mediated and decline in NAD
+ content,
and NAD
+ dependent functions with aging. Oxidative stress to DNA activates PARP leading to poly(ADP-ribosylation) of proteins in a reaction
which consumes NAD
+. Depletion of cellular NAD
+ stores attenuates the activity of Sirt1 deacetylase leading to hyperacetylation of p53, and
consequently tilting the balance to cell death via an apoptotic mechanism.
doi:10.1371/journal.pone.0019194.g010
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